 | • レポートコード：QY2108PAL8900 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおけるオクトレオチドの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、オクトレオチドの種類別市場規模（オクトレオチド注射、オクトレオチド粉末、オクトレオチドミクロスフェア）、用途別市場規模（重度下痢治療、先端巨大症治療、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界のオクトレオチド市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界におけるオクトレオチドの種類別市場規模（2016年-2027年）：オクトレオチド注射、オクトレオチド粉末、オクトレオチドミクロスフェア ・世界におけるオクトレオチドの用途別市場規模（2016年-2027年）：重度下痢治療、先端巨大症治療、その他 ・オクトレオチドの中国市場分析 - オクトレオチドの中国市場規模（2016年-2027年） - 中国におけるオクトレオチドの主要プレイヤー別市場シェア - 中国におけるオクトレオチドの種類別市場規模：オクトレオチド注射、オクトレオチド粉末、オクトレオチドミクロスフェア - 中国におけるオクトレオチドの用途別市場規模：重度下痢治療、先端巨大症治療、その他 ・オクトレオチドの北米市場（2016年-2027年） ・オクトレオチドのヨーロッパ市場（2016年-2027年） ・オクトレオチドのアジア太平洋市場（2016年-2027年） ・オクトレオチドの中南米市場（2016年-2027年） ・オクトレオチドの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Novartis、Sun Pharmaceutical、Chengdu Tiantaishan pharmaceutical、Sinopharm A-Think Pharmaceuticals、Sihuan Pharmaceutical Holdings Group、Shanghai Soho-Yiming Pharmaceuticals、Yibin Pharmaceutical ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
Market Analysis and Insights: Global and China Octreotide Market
This report focuses on global and China Octreotide market.
In 2020, the global Octreotide market size was US$ 3 million and it is expected to reach US$ 3 million by the end of 2027, with a CAGR of -2.8% during 2021-2027. In China the Octreotide market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Octreotide Scope and Market Size
Octreotide market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Octreotide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Octreotide market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Segment by Application
Treating Severe Diarrhea
Treating Acromegaly
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
1 Study Coverage
1.1 Octreotide Product Introduction
1.2 Market by Type
1.2.1 Global Octreotide Market Size Growth Rate by Type
1.2.2 Octreotide Injection
1.2.3 Octreotide Powder
1.2.4 Octreotide Microspheres
1.3 Market by Application
1.3.1 Global Octreotide Market Size Growth Rate by Application
1.3.2 Treating Severe Diarrhea
1.3.3 Treating Acromegaly
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Octreotide Market Size, Estimates and Forecasts
2.1.1 Global Octreotide Revenue 2016-2027
2.1.2 Global Octreotide Sales 2016-2027
2.2 Global Octreotide, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Octreotide Historical Market Size by Region (2016-2021)
2.3.1 Global Octreotide Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Octreotide Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Octreotide Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Octreotide Sales Forecast by Region (2022-2027)
2.4.2 Global Octreotide Revenue Forecast by Region (2022-2027)
3 Global Octreotide Competitor Landscape by Players
3.1 Global Top Octreotide Manufacturers by Sales
3.1.1 Global Octreotide Sales by Manufacturer (2016-2021)
3.1.2 Global Octreotide Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Octreotide Manufacturers by Revenue
3.2.1 Key Octreotide Manufacturers Covered: Ranking by Revenue
3.2.2 Global Octreotide Revenue by Manufacturers (2016-2021)
3.2.3 Global Octreotide Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Octreotide Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Octreotide Revenue in 2020
3.2.6 Global Octreotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Octreotide Price by Manufacturers
3.4 Global Octreotide Manufacturing Base Distribution, Product Types
3.4.1 Octreotide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Octreotide Product Type
3.4.3 Date of International Manufacturers Enter into Octreotide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Octreotide Market Size by Type (2016-2021)
4.1.1 Global Octreotide Sales by Type (2016-2021)
4.1.2 Global Octreotide Revenue by Type (2016-2021)
4.1.3 Octreotide Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Octreotide Market Size Forecast by Type (2022-2027)
4.2.1 Global Octreotide Sales Forecast by Type (2022-2027)
4.2.2 Global Octreotide Revenue Forecast by Type (2022-2027)
4.2.3 Octreotide Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Octreotide Market Size by Application (2016-2021)
5.1.1 Global Octreotide Sales by Application (2016-2021)
5.1.2 Global Octreotide Revenue by Application (2016-2021)
5.1.3 Octreotide Price by Application (2016-2021)
5.2 Octreotide Market Size Forecast by Application (2022-2027)
5.2.1 Global Octreotide Sales Forecast by Application (2022-2027)
5.2.2 Global Octreotide Revenue Forecast by Application (2022-2027)
5.2.3 Global Octreotide Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Octreotide Market Size YoY Growth 2016-2027
6.1.1 China Octreotide Sales YoY Growth 2016-2027
6.1.2 China Octreotide Revenue YoY Growth 2016-2027
6.1.3 China Octreotide Market Share in Global Market 2016-2027
6.2 China Octreotide Market Size by Players (International and Local Players)
6.2.1 China Top Octreotide Players by Sales (2016-2021)
6.2.2 China Top Octreotide Players by Revenue (2016-2021)
6.3 China Octreotide Historic Market Review by Type (2016-2021)
6.3.1 China Octreotide Sales Market Share by Type (2016-2021)
6.3.2 China Octreotide Revenue Market Share by Type (2016-2021)
6.3.3 China Octreotide Price by Type (2016-2021)
6.4 China Octreotide Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Octreotide Sales Forecast by Type (2022-2027)
6.4.2 China Octreotide Revenue Forecast by Type (2022-2027)
6.4.3 China Octreotide Price Forecast by Type (2022-2027)
6.5 China Octreotide Historic Market Review by Application (2016-2021)
6.5.1 China Octreotide Sales Market Share by Application (2016-2021)
6.5.2 China Octreotide Revenue Market Share by Application (2016-2021)
6.5.3 China Octreotide Price by Application (2016-2021)
6.6 China Octreotide Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Octreotide Sales Forecast by Application (2022-2027)
6.6.2 China Octreotide Revenue Forecast by Application (2022-2027)
6.6.3 China Octreotide Price Forecast by Application (2022-2027)
7 North America
7.1 North America Octreotide Market Size YoY Growth 2016-2027
7.2 North America Octreotide Market Facts & Figures by Country
7.2.1 North America Octreotide Sales by Country (2016-2021)
7.2.2 North America Octreotide Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Octreotide Market Size YoY Growth 2016-2027
8.2 Asia Pacific Octreotide Market Facts & Figures by Region
8.2.1 Asia Pacific Octreotide Sales by Region (2016-2021)
8.2.2 Asia Pacific Octreotide Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Octreotide Market Size YoY Growth 2016-2027
9.2 Europe Octreotide Market Facts & Figures by Country
9.2.1 Europe Octreotide Sales by Country (2016-2021)
9.2.2 Europe Octreotide Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Octreotide Market Size YoY Growth 2016-2027
10.2 Latin America Octreotide Market Facts & Figures by Country
10.2.1 Latin America Octreotide Sales by Country (2016-2021)
10.2.2 Latin America Octreotide Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Octreotide Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Octreotide Market Facts & Figures by Country
11.2.1 Middle East and Africa Octreotide Sales by Country (2016-2021)
11.2.2 Middle East and Africa Octreotide Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Octreotide Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Octreotide Products Offered
12.1.5 Novartis Recent Development
12.2 Sun Pharmaceutical
12.2.1 Sun Pharmaceutical Corporation Information
12.2.2 Sun Pharmaceutical Description and Business Overview
12.2.3 Sun Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sun Pharmaceutical Octreotide Products Offered
12.2.5 Sun Pharmaceutical Recent Development
12.3 Chengdu Tiantaishan pharmaceutical
12.3.1 Chengdu Tiantaishan pharmaceutical Corporation Information
12.3.2 Chengdu Tiantaishan pharmaceutical Description and Business Overview
12.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Products Offered
12.3.5 Chengdu Tiantaishan pharmaceutical Recent Development
12.4 Sinopharm A-Think Pharmaceuticals
12.4.1 Sinopharm A-Think Pharmaceuticals Corporation Information
12.4.2 Sinopharm A-Think Pharmaceuticals Description and Business Overview
12.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Products Offered
12.4.5 Sinopharm A-Think Pharmaceuticals Recent Development
12.5 Sihuan Pharmaceutical Holdings Group
12.5.1 Sihuan Pharmaceutical Holdings Group Corporation Information
12.5.2 Sihuan Pharmaceutical Holdings Group Description and Business Overview
12.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Products Offered
12.5.5 Sihuan Pharmaceutical Holdings Group Recent Development
12.6 Shanghai Soho-Yiming Pharmaceuticals
12.6.1 Shanghai Soho-Yiming Pharmaceuticals Corporation Information
12.6.2 Shanghai Soho-Yiming Pharmaceuticals Description and Business Overview
12.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Products Offered
12.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Development
12.7 Yibin Pharmaceutical
12.7.1 Yibin Pharmaceutical Corporation Information
12.7.2 Yibin Pharmaceutical Description and Business Overview
12.7.3 Yibin Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Yibin Pharmaceutical Octreotide Products Offered
12.7.5 Yibin Pharmaceutical Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Octreotide Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novartis Octreotide Products Offered
12.11.5 Novartis Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Octreotide Industry Trends
13.2 Octreotide Market Drivers
13.3 Octreotide Market Challenges
13.4 Octreotide Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Octreotide Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Octreotide Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Octreotide Injection
Table 3. Major Manufacturers of Octreotide Powder
Table 4. Major Manufacturers of Octreotide Microspheres
Table 5. Global Octreotide Market Size Growth Rate by Application (2021-2027) & (Gram)
Table 6. Global Octreotide Market Size by Region (Gram) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Octreotide Sales by Regions (2016-2021) & (Gram)
Table 8. Global Octreotide Sales Market Share by Regions (2016-2021)
Table 9. Global Octreotide Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Octreotide Sales Forecast by Region (2022-2027) & (Gram)
Table 11. Global Octreotide Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Octreotide Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Octreotide Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Octreotide Sales by Manufacturers (2016-2021) (Gram)
Table 15. Global Octreotide Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Octreotide Manufacturers by Revenue (US$ Million) in 2020
Table 17. Octreotide Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Octreotide Revenue Share by Manufacturers (2016-2021)
Table 19. Global Octreotide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Octreotide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Octreotide as of 2020)
Table 21. Key Manufacturers Octreotide Price (2016-2021) (USD/Gram)
Table 22. Octreotide Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Octreotide Product Type
Table 24. Date of International Manufacturers Enter into Octreotide Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Octreotide Sales by Type (2016-2021) (Gram)
Table 27. Global Octreotide Sales Share by Type (2016-2021)
Table 28. Global Octreotide Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Octreotide Revenue Share by Type (2016-2021)
Table 30. Octreotide Average Selling Price (ASP) by Type (2016-2021) & (USD/Gram)
Table 31. Global Octreotide Sales Forecast by Type (2022-2027) & (Gram)
Table 32. Global Octreotide Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Octreotide Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Octreotide Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Octreotide Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Gram)
Table 36. Global Octreotide Sales by Application (2016-2021) (Gram)
Table 37. Global Octreotide Sales Share by Application (2016-2021)
Table 38. Global Octreotide Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Octreotide Revenue Share by Application (2016-2021)
Table 40. Octreotide Average Selling Price (ASP) by Application (2016-2021) & (USD/Gram)
Table 41. Global Octreotide Sales Forecast by Application (2022-2027) & (Gram)
Table 42. Global Octreotide Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Octreotide Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Octreotide Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Octreotide Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Gram)
Table 46. China Octreotide Sales (Gram) of Key Companies (2016-2021)
Table 47. China Octreotide Sales Share by Company (2016-2021)
Table 48. China Octreotide Revenue (US$ Million) by Company (2016-2021)
Table 49. China Octreotide Revenue Share by Company (2016-2021)
Table 50. China Octreotide Sales (Gram) by Type (2016-2021)
Table 51. China Octreotide Sales Share by Type (2016-2021)
Table 52. China Octreotide Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Octreotide Price (USD/Gram) by Type (2016-2021)
Table 54. China Octreotide Sales (Gram) by Type (2022-2027)
Table 55. China Octreotide Sales Share by Type (2022-2027)
Table 56. China Octreotide Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Octreotide Revenue Share by Type (2022-2027)
Table 58. China Octreotide Price (USD/Gram) by Type (2022-2027)
Table 59. China Octreotide Sales (Gram) by Application (2016-2021)
Table 60. China Octreotide Sales Share by Application (2016-2021)
Table 61. China Octreotide Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Octreotide Price (USD/Gram) by Application (2016-2021)
Table 63. China Octreotide Sales (Gram) by Application (2022-2027)
Table 64. China Octreotide Sales Share by Application (2022-2027)
Table 65. China Octreotide Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Octreotide Revenue Share by Application (2022-2027)
Table 67. China Octreotide Price (USD/Gram) by Application (2022-2027)
Table 68. North America Octreotide Sales by Country (2016-2021) & (Gram)
Table 69. North America Octreotide Sales Market Share by Country (2016-2021)
Table 70. North America Octreotide Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Octreotide Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Octreotide Sales by Region (2016-2021) & (Gram)
Table 73. Asia Pacific Octreotide Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Octreotide Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Octreotide Revenue Market Share by Region (2016-2021)
Table 76. Europe Octreotide Sales by Country (2016-2021) & (Gram)
Table 77. Europe Octreotide Sales Market Share by Country (2016-2021)
Table 78. Europe Octreotide Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Octreotide Revenue Market Share by Country (2016-2021)
Table 80. Latin America Octreotide Sales by Country (2016-2021) & (Gram)
Table 81. Latin America Octreotide Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Octreotide Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Octreotide Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Octreotide Sales by Country (2016-2021) & (Gram)
Table 85. Middle East and Africa Octreotide Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Octreotide Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Octreotide Revenue Market Share by Country (2016-2021)
Table 88. Novartis Corporation Information
Table 89. Novartis Description and Business Overview
Table 90. Novartis Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2016-2021)
Table 91. Novartis Octreotide Product
Table 92. Novartis Recent Development
Table 93. Sun Pharmaceutical Corporation Information
Table 94. Sun Pharmaceutical Description and Business Overview
Table 95. Sun Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2016-2021)
Table 96. Sun Pharmaceutical Product
Table 97. Sun Pharmaceutical Recent Development
Table 98. Chengdu Tiantaishan pharmaceutical Corporation Information
Table 99. Chengdu Tiantaishan pharmaceutical Description and Business Overview
Table 100. Chengdu Tiantaishan pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2016-2021)
Table 101. Chengdu Tiantaishan pharmaceutical Product
Table 102. Chengdu Tiantaishan pharmaceutical Recent Development
Table 103. Sinopharm A-Think Pharmaceuticals Corporation Information
Table 104. Sinopharm A-Think Pharmaceuticals Description and Business Overview
Table 105. Sinopharm A-Think Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2016-2021)
Table 106. Sinopharm A-Think Pharmaceuticals Product
Table 107. Sinopharm A-Think Pharmaceuticals Recent Development
Table 108. Sihuan Pharmaceutical Holdings Group Corporation Information
Table 109. Sihuan Pharmaceutical Holdings Group Description and Business Overview
Table 110. Sihuan Pharmaceutical Holdings Group Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2016-2021)
Table 111. Sihuan Pharmaceutical Holdings Group Product
Table 112. Sihuan Pharmaceutical Holdings Group Recent Development
Table 113. Shanghai Soho-Yiming Pharmaceuticals Corporation Information
Table 114. Shanghai Soho-Yiming Pharmaceuticals Description and Business Overview
Table 115. Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2016-2021)
Table 116. Shanghai Soho-Yiming Pharmaceuticals Product
Table 117. Shanghai Soho-Yiming Pharmaceuticals Recent Development
Table 118. Yibin Pharmaceutical Corporation Information
Table 119. Yibin Pharmaceutical Description and Business Overview
Table 120. Yibin Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2016-2021)
Table 121. Yibin Pharmaceutical Product
Table 122. Yibin Pharmaceutical Recent Development
Table 123. Octreotide Market Trends
Table 124. Octreotide Market Drivers
Table 125. Octreotide Market Challenges
Table 126. Octreotide Market Restraints
Table 127. Octreotide Customers List
Table 128. Octreotide Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Octreotide Product Picture
Figure 2. Global Octreotide Sales Market Share by Type in 2020 & 2027
Figure 3. Octreotide Injection Product Picture
Figure 4. Octreotide Powder Product Picture
Figure 5. Octreotide Microspheres Product Picture
Figure 6. Global Octreotide Sales Market Share by Application in 2020 & 2027
Figure 7. Treating Severe Diarrhea
Figure 8. Treating Acromegaly
Figure 9. Others
Figure 10. Octreotide Report Years Considered
Figure 11. Global Octreotide Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Octreotide Market Size 2016-2027 (US$ Million)
Figure 13. Global Octreotide Sales 2016-2027 (Gram)
Figure 14. Global Octreotide Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Octreotide Sales Market Share by Region (2016-2021)
Figure 16. Global Octreotide Sales Market Share by Region in 2020
Figure 17. Global Octreotide Revenue Market Share by Region (2016-2021)
Figure 18. Global Octreotide Revenue Market Share by Region in 2020
Figure 19. Global Octreotide Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Octreotide Revenue in 2020
Figure 21. Octreotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Octreotide Sales Market Share by Type (2016-2021)
Figure 23. Global Octreotide Sales Market Share by Type in 2020
Figure 24. Global Octreotide Revenue Market Share by Type (2016-2021)
Figure 25. Global Octreotide Revenue Market Share by Type in 2020
Figure 26. Global Octreotide Sales Market Share by Application (2016-2021)
Figure 27. Global Octreotide Sales Market Share by Application in 2020
Figure 28. Global Octreotide Revenue Market Share by Application (2016-2021)
Figure 29. Global Octreotide Revenue Market Share by Application in 2020
Figure 30. China Octreotide Sales Growth Rate 2016-2027 (Gram)
Figure 31. China Octreotide Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. China Octreotide Market Share in Global Market 2016-2027
Figure 33. China 5 and 10 Largest Octreotide Players Market Share by Revenue in Octreotide in 2020
Figure 34. China Octreotide Revenue Share by Type (2016-2021)
Figure 35. China Octreotide Revenue Growth Rate by Type in 2016 & 2020
Figure 36. China Octreotide Revenue Share by Application (2016-2021)
Figure 37. China Octreotide Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Octreotide Sales Growth Rate 2016-2021 (Gram)
Figure 39. North America Octreotide Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Octreotide Sales Market Share by Country in 2020
Figure 41. North America Octreotide Revenue Market Share by Country in 2020
Figure 42. U.S. Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 43. U.S. Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 45. Canada Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Octreotide Sales Growth Rate 2016-2021 (Gram)
Figure 47. Europe Octreotide Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Octreotide Sales Market Share by Country in 2020
Figure 49. Europe Octreotide Revenue Market Share by Country in 2020
Figure 50. Germany Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 51. Germany Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 53. France Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 55. U.K. Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 57. Italy Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 59. Russia Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Octreotide Sales Growth Rate 2016-2021 (Gram)
Figure 61. Asia Pacific Octreotide Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Octreotide Sales Market Share by Region in 2020
Figure 63. Asia Pacific Octreotide Revenue Market Share by Region in 2020
Figure 64. China Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 65. China Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 67. Japan Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 69. South Korea Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 71. India Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 73. Australia Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. China Taiwan Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 75. China Taiwan Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 77. Indonesia Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 79. Thailand Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 81. Malaysia Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Latin America Octreotide Sales Growth Rate 2016-2021 (Gram)
Figure 83. Latin America Octreotide Revenue Growth Rate 2016-2021 (US$ Million)
Figure 84. Latin America Octreotide Sales Market Share by Country in 2020
Figure 85. Latin America Octreotide Revenue Market Share by Country in 2020
Figure 86. Mexico Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 87. Mexico Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Brazil Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 89. Brazil Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Argentina Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 91. Argentina Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Middle East and Africa Octreotide Sales Growth Rate 2016-2021 (Gram)
Figure 93. Middle East and Africa Octreotide Revenue Growth Rate 2016-2021 (US$ Million)
Figure 94. Middle East and Africa Octreotide Sales Market Share by Country in 2020
Figure 95. Middle East and Africa Octreotide Revenue Market Share by Country in 2020
Figure 96. Turkey Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 97. Turkey Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Saudi Arabia Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 99. Saudi Arabia Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. UAE Octreotide Sales Growth Rate (2016-2021) (Gram)
Figure 101. UAE Octreotide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Octreotide Value Chain
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Bottom-up and Top-down Approaches for This Report
Figure 106. Data Triangulation
Figure 107. Key Executives Interviewed
オクトレオチドの世界市場 2020年 Market Overview The Octreotide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…- 癌治療用チェックポイント阻害剤の世界及び中国市場 Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are block…
- ソマトスタチン薬の世界市場 2020年 Market Overview The global Somatostatin Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Somatostatin Drugs market …
- ソマトスタチン・ソマトスタチン類似体の世界市場 2020年 Market Overview The global Somatostatin and Somatostatin Analogs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Somatos…
- 成長ホルモン抑制ホルモンの世界市場 2020年 Market Overview The global Growth Hormone-inhibiting Hormone market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Growth Horm…